Genetics of cluster headache: an update by unknown
Introduction
Cluster headache (CH) is a primary headache disorder
characterised by attacks of severe unilateral, retro-orbital
pain accompanied by restlessness and cranial autonomic
symptoms, such as lacrimation or conjunctival injection.
The signature feature of the disease is its periodicity and
the patients present a striking unique diurnal and seasonal
rhythmicity [1].
The aetiology of CH is still unknown. Up to a few years
ago, CH was not thought to be an inherited disorder.
However, several recent studies have suggested that genet-
ic factors play an important role in the disease. In some fam-
ilies, the CH phenotype is inherited as an autosomal domi-
nant trait [2, 3]. In comparison with the general population,
both first- and second-degree relatives of CH patients have
a significantly increased risk for the disease [4, 5]. Finally,
some cases of monozygotic twin pairs concordant for CH
have been reported in the literature [6]. At present, howev-
er, the type and the number of the genes involved in CH are
still unclear. No mutation in CACNA1A and NOS genes has
been found in CH patients. We have recently described a
significant association between a HCRTR2 gene polymor-
phism and the disease. The purpose of this review is to
describe recent advances in the genetics of CH.
Familial studies
In 1974, Ekbom reported on three small families with mul-
tiple CH patients [7]. Since then, several families with CH
in multiple generations have been described in the litera-
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Abstract Up to a few years ago,
cluster headache (CH) was not
thought to be an inherited disorder.
However, several recent studies
have suggested that genetic factors
play a role in the disease. Genetic
epidemiological surveys have
shown that first-degree relatives of
CH patients are more likely to have
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ture. A positive family history for the disease was found in
1.9%–20.0% of patients with CH, suggesting a role for
genetic factors in the disease [8]. A recent study compared
the clinical characteristics of patients with familial and
non-familial CH [9]. The study did not show any signifi-
cant differences in symptoms between the two CH groups,
such as pain location, accompanying symptoms, duration
and frequency of attacks, and active periods.
Anticipation (the tendency for some disorders to pre-
sent at an earlier age in successive generations) has been
described in some families with CH. At present, however,
it is not clear if the anticipation observed in some families
is a true phenomenon or a study bias. CH has been asso-
ciated with primary hyperlipidaemia in one family and
haemochromatosis in another family. This is likely to be
the coincidental co-occurrence of two disorders.
Epidemiological surveys
Several genetic epidemiological surveys evaluated the dis-
ease risk of relatives of CH probands [4, 5]. First-degree rel-
atives had a 5–18 times higher risk while second-degree rel-
atives had a one to three times higher risk of CH than the gen-
eral population. The different results can be partly explained
by methodological differences. The increased familial risk of
CH strongly suggests a genetic cause for the disease.
Twin studies
At present, CH has been reported in six concordant
monozygotic twin pairs. This indicates the importance of
genetic factors, although publication itself introduces
selection bias. In a recent, large twin survey based on the
Swedish Twin Registry and the Swedish Inpatient
Registry, the two monozygotic and nine dizygotic twin
pairs were all discordant for CH and had been discordant
for 10–31 years [10]. The twin data support the impor-
tance of both genetic and environmental factors.
Segregation analysis
In families with multiple affected members, all types of dis-
ease transmission have been observed: from father to son,
father to daughter, mother to son and mother to daughter.
A complex segregation analysis of CH suggested that
an autosomal dominant gene has a role in some families
with CH [11]. The penetrance is lower in women than in
men. Multifactorial inheritance is the most likely explana-
tion in the sporadic cases.
Molecular genetics of cluster headache
At present, no clear molecular genetic clues have been
identified for CH. A study of a Japanese man with sporadic
CH reported a mutation in mitochondrial transfer
RNAleu(UUR) gene at nucleotide pair 3243 [12]. However,
this mutation was not detected in Italian and German
patients with CH [13, 14] and the involvement of mito-
chondrial genes in CH remains unproven. The paroxysmal
character of CH suggests that ion-channel genes are candi-
date genes for the disease. Familial Hemiplegic Migraine, a
rare subtype of migraine with aura, cosegregates with muta-
tions in the CACNA1A gene, a gene that encodes for a P/Q
type neuronal calcium channel [15]. A Swedish association
found no linkage disequilibrium between polymorphisms
of the CACNA1A gene and CH [16]. A Dutch haplotype
study of a family with three affected members, followed by
a subsequent mutation analysis of the gene, provided no
data supporting a role for this gene in CH [17]. Nitric oxide
has been implicated in the pathophysiology of CH. So, a
Swedish association study investigated several polymor-
phisms of NOS1, NOS2A and NOS3 genes and found no
difference between CH patients and controls [18].
Observations of circadian biological changes and neu-
roendocrine disturbances have suggested a fundamental
role for the hypothalamus in CH. Brain imaging studies
with PET and voxel-based morphometry have identified
the posterolateral hypothalamic grey matter as the key
area for the basic defect in the disease [19]. Hypocretin-1
and -2 (also called orexin-A and -B) are newly discovered
neuropeptides processed from a common precursor, pre-
prohypocretin. Hypocretin-containing cells are located
exclusively in the lateral hypothalamus, with widespread
projections to the entire neuroaxis. We performed an asso-
ciation study between polymorphism of hypocretin/orexin
pathway genes (HCRT, HCRTR1 and HCRTR2) and the
disease in a large cohort of Italian CH patients. A highly
significant association between the 1246 G>A polymor-
phism of the HCRTR2 gene and CH was found, suggest-
ing that the HCTR2 gene or a linked locus significantly
modulates the risk for CH [20].
Conclusion
Several epidemiological studies have clearly demonstrated
that genetic factors play a role in CH. At present, however,
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the type and the number of genes involved in the disease are
still unclear. We have described the first significant associa-
tion between CH and a polymorphism of the HCRTR2 gene.
Additional studies are needed to search for susceptibility
genes for CH in this chromosomal region. Furthermore,
considering the paroxysmal character and periodicity of the
disease, ion-channel genes and clock genes may be analysed
as candidate genes for cluster headache.
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